News
Home  >  News > The UB becomes a shareholder of Reveal Genomics, a spin-off born to develop...

The UB becomes a shareholder of Reveal Genomics, a spin-off born to develop innovative diagnostic tests in oncology

Aleix Prat (Hospital Clínic-UB) and Patricia Villagrasa-González (Reveal Genomics).

Aleix Prat (Hospital Clínic-UB) and Patricia Villagrasa-González (Reveal Genomics).

14/05/2021

Recerca

The University of Barcelona has become a shareholder of Reveal Genomics, a spin-off of Hospital Clínic and Vall d’Hebron Institute of Oncology (VHIO), which plans to develop and market precision diagnostic tools in oncology based on he combination of different genomic data. First, the spin-off will focus on the improvement of breast cancer diagnosis with tools that enable them to personalize the treatment of the disease.

 

Further information

 

 

Share this at:
| More |
  • Follow us:
  • Button to access University of Barcelona's Facebook profile
  • Button to access University of Barcelona's Twitter profile
  • Button to access University of Barcelona's Instagram profile
  • Button to access University of Barcelona's Linkedin profile
  • Button to access University of Barcelona's Youtube profile
  • Button to access University of Barcelona's Google+ profile
  • ??? peu.flickr.alt ???
Member of International recognition of excellence HR Excellence in Research logo del leru - League of European Research Universities logo del bkc - campus excel·lència logo del health universitat de barcelona campus

© Universitat de Barcelona